Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,775 | 27,725 | 46,517 | 37,499 | 19,581 |
| Marketable Securities | 31,094 | 51,319 | 51,850 | 91,629 | 131,629 |
| Receivables | 165 | 281 | 471 | 790 | 895 |
| Other current assets | 23,849 | 0 | 0 | 0 | 0 |
| TOTAL | $87,820 | $86,667 | $105,408 | $134,554 | $159,362 |
| Non-Current Assets | |||||
| PPE Net | 1,494 | 39,177 | 39,959 | 41,362 | 41,838 |
| Intangibles | 98,100 | 98,100 | 98,100 | 98,100 | 98,100 |
| Other Non-Current Assets | 108 | 120 | 133 | 144 | 158 |
| TOTAL | $99,702 | $137,397 | $138,192 | $139,606 | $140,096 |
| Total Assets | $187,522 | $224,064 | $243,600 | $274,160 | $299,458 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,609 | 1,783 | 1,746 | 1,710 | 1,675 |
| Accounts payable and accrued liabilities | 9,741 | 8,350 | 7,072 | 9,715 | 9,709 |
| Accrued Expenses | 13,134 | 10,886 | 7,952 | 7,674 | 11,529 |
| TOTAL | $44,269 | $21,896 | $17,673 | $19,294 | $23,598 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 19,255 | 19,711 | 20,167 | 20,609 |
| Deferred Revenues | 785 | 877 | 903 | 195 | 685 |
| Other Non-Current Liabilities | 34,005 | 34,821 | 34,017 | 32,386 | 37,391 |
| TOTAL | $65,429 | $85,500 | $85,152 | $84,703 | $90,150 |
| Total Liabilities | $109,698 | $107,396 | $102,825 | $103,997 | $113,748 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,570 | 73,568 | 73,585 | 73,421 | 73,382 |
| Common Shares | 516 | 516 | 516 | 514 | 514 |
| Retained earnings | -1,101,319 | -1,060,821 | -1,034,793 | -1,003,958 | -986,544 |
| Other shareholders' equity | -388 | -385 | -380 | 499 | 535 |
| TOTAL | $77,824 | $116,668 | $140,775 | $170,163 | $185,710 |
| Total Liabilities And Equity | $187,522 | $224,064 | $243,600 | $274,160 | $299,458 |